Focus Partners Wealth Cuts Stock Position in Astera Labs, Inc. $ALAB

Focus Partners Wealth lessened its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 25.1% in the 3rd quarter, HoldingsChannel reports. The fund owned 325,243 shares of the company’s stock after selling 108,788 shares during the period. Focus Partners Wealth’s holdings in Astera Labs were worth $63,652,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Assetmark Inc. boosted its stake in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares in the last quarter. Pinpoint Asset Management Singapore Pte. Ltd. acquired a new position in shares of Astera Labs during the third quarter worth $47,000. Whittier Trust Co. purchased a new stake in shares of Astera Labs during the 3rd quarter valued at $55,000. Ramirez Asset Management Inc. purchased a new stake in shares of Astera Labs during the 3rd quarter valued at $59,000. Finally, Atlantic Union Bankshares Corp boosted its position in shares of Astera Labs by 1,338.1% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock worth $59,000 after purchasing an additional 281 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of ALAB stock opened at $127.48 on Tuesday. The business has a fifty day moving average of $147.10 and a 200 day moving average of $167.60. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The firm has a market capitalization of $21.70 billion, a price-to-earnings ratio of 104.49, a price-to-earnings-growth ratio of 2.37 and a beta of 1.75.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In related news, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief executive officer owned 1,452,739 shares in the company, valued at $179,863,615.59. This represents a 6.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Michael Truett Tate sold 12,001 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the completion of the transaction, the chief financial officer owned 192,083 shares in the company, valued at approximately $23,781,796.23. This trade represents a 5.88% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 224,292 shares of company stock valued at $27,676,069 over the last quarter. Company insiders own 12.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on ALAB shares. Raymond James Financial began coverage on Astera Labs in a research note on Friday, November 21st. They set a “hold” rating on the stock. Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Royal Bank Of Canada initiated coverage on Astera Labs in a research note on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target on the stock. Northland Securities upped their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Finally, BNP Paribas Exane assumed coverage on shares of Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $202.22.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.